AI assistant
Sending…
WEYCO GROUP INC — Director's Dealing 2025
Nov 10, 2025
33363_dirs_2025-11-10_7b98a4ac-c906-40fd-88de-7410a40497d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEYCO GROUP INC (WEYS)
CIK: 0000106532
Period of Report: 2025-11-06
Reporting Person: Douglass Jeffrey S (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-06 | Common Stock | M | 500 | $18 | Acquired | 8706 | Direct |
| 2025-11-06 | Common Stock | M | 500 | $24 | Acquired | 9206 | Direct |
| 2025-11-06 | Common Stock | M | 1550 | $25.79 | Acquired | 10756 | Direct |
| 2025-11-06 | Common Stock | F | 1945 | $31.35 | Disposed | 8811 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-06 | Stock Option | $18 | M | 500 | Disposed | 2030-08-26 | Common Stock (500) | Direct |
| 2025-11-06 | Stock Option | $24 | M | 500 | Disposed | 2031-08-25 | Common Stock (1000) | Direct |
| 2025-11-06 | Stock Option | $25.79 | M | 1550 | Disposed | 2033-08-25 | Common Stock (3900) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $37.22 | 2028-08-23 | Common Stock (1200) | 1200 | Direct |
| Stock Option | $28.83 | 2032-08-25 | Common Stock (2513) | 2513 | Direct |
Footnotes
F1: 20% per year for 5 years beginning 08/26/2021
F2: 20% per year for 5 years beginning 08/25/2022
F3: 20% per year for 5 years beginning 08/25/2024
F4: 20% per year for 5 years beginning 08/23/2019
F5: 20% per year for 5 years beginning 08/25/2023
More from WEYCO GROUP INC
Regulatory Filings
2026
May 28
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Annual Report
2026
Mar 13
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Jan 5
Director's Dealing
2025
Dec 30